Organon EPS Diluted (Quarterly) Trends

Organon & Co (OGN)

18.07 -0.71 (-3.78%) USD | NYSE | Nov 01, 16:00

18.02 -0.05 (-0.28%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	1.38
June 30, 2024	0.75
March 31, 2024	0.78
December 31, 2023	2.13
September 30, 2023	0.23
June 30, 2023	0.95
March 31, 2023	0.69
December 31, 2022	0.42
September 30, 2022	0.89
June 30, 2022	0.92

Date	Value
March 31, 2022	1.36
December 31, 2021	0.79
September 30, 2021	1.27
June 30, 2021	1.68
March 31, 2021	1.576
December 31, 2020	1.454
September 30, 2020	2.161
June 30, 2020	2.141
March 31, 2020	2.777

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

0.23

Minimum

Sep 2023

2.777

Maximum

Mar 2020

1.282

Average

1.27

Median

Sep 2021

EPS Diluted (Quarterly) Benchmarks

Eli Lilly and Co	1.07
Biomarin Pharmaceutical Inc	0.55
Cassava Sciences Inc	0.13
Ligand Pharmaceuticals Inc	-2.88
TG Therapeutics Inc	0.04

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	359.00M
Revenue (Quarterly)	1.582B
Total Expenses (Quarterly)	1.192B
Enterprise Value	12.64B
Gross Profit Margin (Quarterly)	58.34%
Profit Margin (Quarterly)	22.69%
Earnings Yield	27.89%
Operating Earnings Yield	32.18%
Normalized Earnings Yield	31.18